Search

Your search keyword '"Sainz, L."' showing total 298 results

Search Constraints

Start Over You searched for: Author "Sainz, L." Remove constraint Author: "Sainz, L."
298 results on '"Sainz, L."'

Search Results

11. Protocol for nutritional risk in oncology (PRONTO) novel awareness tool: The nutripronto study preliminary results

13. EP13.01-12 Validation of LIPI index in SCLC

14. EP13.01-11 Study of NLI Use in the First Line of Atezolizumab Plus Chemotherapy

15. EP11.03-05 Molecular Characterization and Prognosis of Patients with KRAS Mutant Non-small Cell Lung Cancer

17. EP13.03-03 RWD of Atezolizumab Plus Chemotherapy in First Line SCLC

18. EP16.02-014 A Comparative Analysis of Gene Alteration Detected With NGS in Tumor Tissue and Peripheral Blood in Lung Cancer

19. EP16.01-007 Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy

20. EP08.02-088 Mutational Status of KRAS, STK11 and CDKN2A Genes as Predictors of Response to Antiangiogenic Agents in Non-small Cell Lung Cancer Patients

21. EP08.01-048 Spanish Immunotherapy Registry of Cardiovascular Toxicity (SIR-CVT): Preliminary Analysis of the Lung Cancer Cohort

24. 1850P Management and potential factors of immunotoxicity in patients with metastatic non-small cell lung cancer receiving first-line treatment with immune checkpoint inhibitors

25. 1809P Validation of the lung inmune prognostic (LIPI) index in first-line immunotherapy treatment of small cell lung carcinoma

27. 1227P Update on the analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1

28. P-41 What to expect from best supportive care as initial approach for newly-diagnosed colorectal cancer: A single institution experience

29. P-87 Clinical score to predict recurrence in patients with stage II and III colon cancer

40. PSPICE computer model of a nonlinear three-phase three-legged transformer

41. Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience

42. Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy

43. Infeasible harmonic power flow study solutions

48. Variation in antiosteoporotic drug prescribing and spending across Spain. A population-based ecological cross-sectional study

49. P2.01-55 Immunotherapy First or After Nintedanib?: A Spanish Experience

50. Incidence of vascular thromboembolism events in cancer patients receiving immunotherapy: A single institution experience

Catalog

Books, media, physical & digital resources